These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 25336150)
21. Conjugation of sulfonated aluminum phthalocyanine to doxorubicin can improve the efficacy of photodynamic cancer therapy. Qin YL; Huang X; Chen JY Anticancer Drugs; 2012 Nov; 23(10):1047-53. PubMed ID: 22797175 [TBL] [Abstract][Full Text] [Related]
22. Water-soluble non-aggregating zinc phthalocyanine and in vitro studies for photodynamic therapy. Makhseed S; Machacek M; Alfadly W; Tuhl A; Vinodh M; Simunek T; Novakova V; Kubat P; Rudolf E; Zimcik P Chem Commun (Camb); 2013 Dec; 49(95):11149-51. PubMed ID: 24040651 [TBL] [Abstract][Full Text] [Related]
23. Mono- and tetra-substituted zinc(II) phthalocyanines containing morpholinyl moieties: Synthesis, antifungal photodynamic activities, and structure-activity relationships. Zheng BY; Ke MR; Lan WL; Hou L; Guo J; Wan DH; Cheong LZ; Huang JD Eur J Med Chem; 2016 May; 114():380-9. PubMed ID: 27046231 [TBL] [Abstract][Full Text] [Related]
24. A naphthalocyanine based near-infrared photosensitizer: synthesis and in vitro photodynamic activities. Luan L; Ding L; Zhang W; Shi J; Yu X; Liu W Bioorg Med Chem Lett; 2013 Jul; 23(13):3775-9. PubMed ID: 23721806 [TBL] [Abstract][Full Text] [Related]
25. Cervical cancer cells (HeLa) response to photodynamic therapy using a zinc phthalocyanine photosensitizer. Hodgkinson N; Kruger CA; Mokwena M; Abrahamse H J Photochem Photobiol B; 2017 Dec; 177():32-38. PubMed ID: 29045918 [TBL] [Abstract][Full Text] [Related]
26. Highly photocytotoxic 1,4-dipegylated zinc(II) phthalocyanines. Effects of the chain length on the in vitro photodynamic activities. Liu JY; Jiang XJ; Fong WP; Ng DK Org Biomol Chem; 2008 Dec; 6(24):4560-6. PubMed ID: 19039364 [TBL] [Abstract][Full Text] [Related]
27. Highly positive-charged zinc(II) phthalocyanine as non-aggregated and efficient antifungal photosensitizer. Li XS; Guo J; Zhuang JJ; Zheng BY; Ke MR; Huang JD Bioorg Med Chem Lett; 2015 Jun; 25(11):2386-9. PubMed ID: 25911302 [TBL] [Abstract][Full Text] [Related]
33. A phthalocyanine-peptide conjugate with high in vitro photodynamic activity and enhanced in vivo tumor-retention property. Ke MR; Yeung SL; Fong WP; Ng DK; Lo PC Chemistry; 2012 Apr; 18(14):4225-33. PubMed ID: 22378352 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and comparative photodynamic properties of two isosteric alkyl substituted zinc(II) phthalocyanines. Gauna GA; Marino J; García Vior MC; Roguin LP; Awruch J Eur J Med Chem; 2011 Nov; 46(11):5532-9. PubMed ID: 21955680 [TBL] [Abstract][Full Text] [Related]
35. Alginate-zinc (II) phthalocyanine conjugates: Synthesis, characterization and tumor-associated macrophages-targeted photodynamic therapy. Tang F; Xie W; Li S; Hu Q; Zheng B; Ke M; Huang J Carbohydr Polym; 2020 Jul; 240():116239. PubMed ID: 32475548 [TBL] [Abstract][Full Text] [Related]
36. Peptide-substituted phthalocyanine photosensitizers: design, synthesis, photophysicochemical and photobiological studies. Göksel M; Durmuş M; Atilla D Photochem Photobiol Sci; 2016 Oct; 15(10):1318-1329. PubMed ID: 27714248 [TBL] [Abstract][Full Text] [Related]
37. A non-aggregated silicon(IV) phthalocyanine-lactose conjugate for photodynamic therapy. Li D; Hu QY; Wang XZ; Li X; Hu JQ; Zheng BY; Ke MR; Huang JD Bioorg Med Chem Lett; 2020 Jun; 30(12):127164. PubMed ID: 32291134 [TBL] [Abstract][Full Text] [Related]
38. A tumor-targeted activatable phthalocyanine-tetrapeptide-doxorubicin conjugate for synergistic chemo-photodynamic therapy. Ke MR; Chen SF; Peng XH; Zheng QF; Zheng BY; Yeh CK; Huang JD Eur J Med Chem; 2017 Feb; 127():200-209. PubMed ID: 28063352 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of photodynamic treatment using aluminum phthalocyanine tetrasulfonate chloride as a photosensitizer: new approach. Amin RM; Hauser C; Kinzler I; Rueck A; Scalfi-Happ C Photochem Photobiol Sci; 2012 Jul; 11(7):1156-63. PubMed ID: 22402592 [TBL] [Abstract][Full Text] [Related]
40. Development of targeted photodynamic therapy drugs by combining a zinc phthalocyanine sensitizer with TSPO or EGFR binding groups: the impact of the number of targeting agents on biological activity. Toubia I; Nguyen C; Diring S; Onofre M; Daurat M; Gauthier C; Gary-Bobo M; Kobeissi M; Odobel F Org Biomol Chem; 2023 Aug; 21(32):6509-6523. PubMed ID: 37341568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]